July 30, 2024Open Access

Polymyxin B Plus Aerosolized Colistin vs Polymyxin B Alone in Hospital-acquired Pneumonia (“AEROCOL” Study): A Feasibility Study

Key Points

Key points are not available for this paper at this time.

Abstract

In hospital-acquired pneumonia (HAP) due to extensively drug resistant gram-negative pathogens, can treatment with high-dose colistin aerosolization using specific aerosol delivery protocol, improve clinical outcome in addition to systemic polymyxin-B?

Read Full Paperexternally

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Cite This Study

Supradip Ghosh (Tue,) studied this question.

synapsesocial.com/papers/68e5e6efb6db64358757bb9d https://doi.org/https://doi.org/10.5005/jp-journals-10071-24767

Discussion

Journals

Indian Journal of Critical Care Medicine

Institutions

Fortis Escorts Hospital

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.